<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71851-005-01
</NDCCode>
<PackageDescription>
4 mL in 1 VIAL (71851-005-01)
</PackageDescription>
<NDC11Code>
71851-0005-01
</NDC11Code>
<ProductNDC>
71851-005
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Pemivibart
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20240322
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
WuXi Biologics Co., Ltd
</LabelerName>
<SubstanceName>
PEMIVIBART
</SubstanceName>
<StrengthNumber>
125
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2024-05-24
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
22-MAR-24
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>